Appropriation et régulation des innovations biotechnologiques : pour une comparaison transatlantique

This article analyzes two biotechnological innovations — the tests of tracking the genetic risks of diseases and the transgenic organisms — and explores the controversies concerning the status of these new knowledges and the ways there are applied. It shows how these innovations were received in a different way in the United States and in France. The market regulation, which is strong in the USA is problematic in France. It is marginalized by the professional regulation in the case of the genetic tests. And in the other case it is limited by the control of the state, which constitutes some resources for the mobilization of the civil society against transgenic organisms. Finally the comparison consolidates the hypothesis of the emergence of a new regime of production of the knowledge, specified by the tension between a “market” regulation and a “consumerist-civic” regulation.